Mirati Therapeutics
MRTX
#2995
Rank
S$5.58 B
Marketcap
$79.55
Share price
0.00%
Change (1 day)
52.35%
Change (1 year)

Revenue for Mirati Therapeutics (MRTX)

Revenue in 2023 (TTM): S$51.73 Million

According to Mirati Therapeutics's latest financial reports the company's current revenue (TTM ) is S$51.75 Million. In 2022 the company made a revenue of S$16.67 Million a decrease over the revenue in the year 2021 that were of S$97.46 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mirati Therapeutics from 2005 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) S$51.73 M210.34%
2022 S$16.67 M-82.89%
2021 S$97.46 M449.82%
2020 S$17.72 M294.25%
2019 S$4.49 M-74.54%
2018 S$17.65 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A-100%
2012 -S$0.01 Million-100%
2011 S$4.14 M34.96%
2010 S$3.07 M-16.4%
2009 S$3.67 M-89.52%
2008 S$35.05 M63.41%
2007 S$21.45 M2.1%
2006 S$21 M125.11%
2005 S$9.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$14.61 B 28,144.71%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas